New York State Common Retirement Fund Increases Stock Holdings in Mirion Technologies, Inc. $MIR

New York State Common Retirement Fund boosted its stake in Mirion Technologies, Inc. (NYSE:MIR) by 27.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 169,875 shares of the company’s stock after acquiring an additional 36,694 shares during the quarter. New York State Common Retirement Fund’s holdings in Mirion Technologies were worth $3,951,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of MIR. JPMorgan Chase & Co. raised its holdings in Mirion Technologies by 187.2% during the second quarter. JPMorgan Chase & Co. now owns 825,269 shares of the company’s stock worth $17,768,000 after purchasing an additional 537,900 shares in the last quarter. Louisiana State Employees Retirement System acquired a new position in shares of Mirion Technologies during the 3rd quarter valued at $2,438,000. Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Mirion Technologies by 76.8% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 417,790 shares of the company’s stock worth $9,718,000 after buying an additional 181,450 shares in the last quarter. Munro Partners lifted its holdings in shares of Mirion Technologies by 64.0% in the third quarter. Munro Partners now owns 199,910 shares of the company’s stock valued at $4,650,000 after buying an additional 78,035 shares during the period. Finally, New York State Teachers Retirement System bought a new position in Mirion Technologies during the third quarter valued at about $1,269,000. Institutional investors and hedge funds own 78.51% of the company’s stock.

Insider Buying and Selling

In other Mirion Technologies news, Director Lawrence D. Kingsley sold 350,000 shares of Mirion Technologies stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $24.73, for a total transaction of $8,655,500.00. Following the transaction, the director directly owned 3,509,075 shares in the company, valued at approximately $86,779,424.75. The trade was a 9.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 6.30% of the company’s stock.

Mirion Technologies Stock Performance

Mirion Technologies stock opened at $24.07 on Friday. The firm’s 50 day simple moving average is $24.94 and its 200-day simple moving average is $23.92. The company has a market cap of $6.11 billion, a P/E ratio of 218.84 and a beta of 0.97. The company has a debt-to-equity ratio of 0.63, a current ratio of 4.83 and a quick ratio of 4.32. Mirion Technologies, Inc. has a fifty-two week low of $12.00 and a fifty-two week high of $30.28.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MIR. JPMorgan Chase & Co. upped their price target on shares of Mirion Technologies from $28.00 to $34.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Morgan Stanley assumed coverage on shares of Mirion Technologies in a research note on Friday, January 23rd. They set an “equal weight” rating and a $29.00 target price for the company. Evercore started coverage on shares of Mirion Technologies in a research report on Tuesday, November 25th. They issued an “outperform” rating and a $29.00 price target on the stock. Finally, Citigroup dropped their price target on Mirion Technologies from $35.00 to $33.00 and set a “buy” rating on the stock in a report on Monday, December 8th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Mirion Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $28.38.

About Mirion Technologies

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.